Total Funding
65
52
Total FundingDebt Financing raised
Growth Score 65 in past quarter
-5 pts
Heat Score 52 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
110445
Quantitative Cell Diagnostix manufactures medical devices to help in the detection of rare cells in blood circulation.
Harry H. Penner: Co-FounderPast Role: Marinus Pharmaceuticals, Co - Founder & Board of Directors- Triantafyllos Tafas: Co-Founder, CEO, and Director
About the Company
Quantitative Cell Diagnostix designs, manufactures, and sells instruments, consumables, and reagents to help in the detection of rare cells in blood circulation. QCDx's mission is to reveal circulating tumor cell heterogeneity early in cancer onset and throughout the disease trajectory to deliver precision cancer diagnosis that will guide the
clinical oncologist to optimize treatment, monitor therapy, characterize metastasis, and assess treatment toxicity.